The history of Viagra and its parent , copyright, presents a fascinating picture for prospective investors. While the revolutionary drug initially produced enormous profits , its patent has lapsed , leading to generic options flooding the landscape . This decline in value presents a real hurdle for copyright and any fund considering a large stake i